Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy.

Although anti-PD-1 immunotherapy is widely used to treat melanoma, its efficacy still has to be improved. In this work, we present a therapeutic method that combines immunotherapy and starvation therapy to achieve better antitumor efficacy. We designed the CMSN-GOx method, in which mesoporous silica nanoparticles (MSN) are loaded with glucose oxidase (GOx) and then encapsulate the surfaces of cancer cell membranes to realize starvation therapy. By functionalizing the MSN's biomimetic surfaces, we can synthesize nanoparticles that can escape the host immune system and homologous target. These attributes enable the nanoparticles to have improved cancer targeting ability and enrichment in tumor tissues. Our synthetic CMSN-GOx complex can ablate tumors and induce dendritic cell maturity to stimulate an antitumor immune response. We performed an in vivo analysis of these nanoparticles and determined that our combined therapy CMSN-GOx plus PD-1 exhibits a better antitumor therapeutic effect than therapies using CMSN-GOx or PD-1 alone. Additionally, we used the positron emission tomography imaging to measuring the level of glucose metabolism in tumor tissues, for which we investigate the effect with the cancer therapy in vivo.

[1]  Y. Anraku,et al.  Therapeutic Vesicular Nanoreactors with Tumor-Specific Activation and Self-Destruction for Synergistic Tumor Ablation. , 2017, Angewandte Chemie.

[2]  Zhuang Liu,et al.  Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses , 2017, Nature Communications.

[3]  Jianlin Shi,et al.  Tumor-selective catalytic nanomedicine by nanocatalyst delivery , 2017, Nature Communications.

[4]  Hong Cheng,et al.  Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy. , 2017, ACS nano.

[5]  Zhen Yuan,et al.  Enhanced Phototherapy by Nanoparticle-Enzyme via Generation and Photolysis of Hydrogen Peroxide. , 2017, Nano letters.

[6]  Shuming Nie,et al.  Surface-Enhanced Raman Scattering Active Gold Nanoparticles with Enzyme-Mimicking Activities for Measuring Glucose and Lactate in Living Tissues. , 2017, ACS nano.

[7]  Yoosoo Yang,et al.  Virus‐Mimetic Fusogenic Exosomes for Direct Delivery of Integral Membrane Proteins to Target Cell Membranes , 2017, Advanced materials.

[8]  Wei Liu,et al.  Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy. , 2017, ACS nano.

[9]  Xingzhong Zhao,et al.  Antitumor Platelet‐Mimicking Magnetic Nanoparticles , 2017 .

[10]  Yi Liu,et al.  Glucose-Responsive Sequential Generation of Hydrogen Peroxide and Nitric Oxide for Synergistic Cancer Starving-Like/Gas Therapy. , 2017, Angewandte Chemie.

[11]  R. Weichselbaum,et al.  Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer. , 2016, Journal of the American Chemical Society.

[12]  Ligeng Xu,et al.  Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy , 2016, Nature Communications.

[13]  R. Weichselbaum,et al.  Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy. , 2016, Journal of the American Chemical Society.

[14]  Quanyin Hu,et al.  Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors. , 2016, ACS nano.

[15]  D. Mooney,et al.  Biomaterials for enhancing anti-cancer immunity. , 2016, Current opinion in biotechnology.

[16]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[17]  Zhen Gu,et al.  Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody. , 2016, Nano letters.

[18]  W. Liu,et al.  Cancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging , 2016, Advanced materials.

[19]  F. Hodi,et al.  Melanoma in 2015: Immune-checkpoint blockade — durable cancer control , 2016, Nature Reviews Clinical Oncology.

[20]  W. Liu,et al.  Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance. , 2015, Small.

[21]  Melody A Swartz,et al.  Engineering opportunities in cancer immunotherapy , 2015, Proceedings of the National Academy of Sciences.

[22]  J. Wolchok,et al.  Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  D. Mooney,et al.  Engineered Materials for Cancer Immunotherapy. , 2015, Nano today.

[24]  W. Hagopian,et al.  Anti–PD-1 and Anti–PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes , 2015, Diabetes Care.

[25]  C. Drake,et al.  Immune checkpoint blockade: a common denominator approach to cancer therapy. , 2015, Cancer cell.

[26]  P. Sharma,et al.  Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential , 2015, Cell.

[27]  P. Sharma,et al.  The future of immune checkpoint therapy , 2015, Science.

[28]  N. Bhardwaj,et al.  Cancer immunotherapy: Dendritic-cell vaccines on the move , 2015, Nature.

[29]  Weibo Cai,et al.  Positron emission tomography imaging using radiolabeled inorganic nanomaterials. , 2015, Accounts of chemical research.

[30]  Ligeng Xu,et al.  Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti‐CTLA‐4 Therapy to Inhibit Cancer Metastasis , 2014, Advanced materials.

[31]  Xingzhong Zhao,et al.  Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery. , 2014, ACS nano.

[32]  Ronnie H. Fang,et al.  Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery , 2014, Nano letters.

[33]  Yan Zheng,et al.  Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment. , 2013, Current opinion in immunology.

[34]  Subinoy Rana,et al.  Nanoparticles for detection and diagnosis. , 2010, Advanced drug delivery reviews.

[35]  Marina A Dobrovolskaia,et al.  Nanoparticles and the immune system. , 2010, Endocrinology.

[36]  Weibo Cai,et al.  Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.

[37]  D. Pardoll,et al.  Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.

[38]  P. Sly,et al.  Bidirectional Interactions between Antigen-bearing Respiratory Tract Dendritic Cells (DCs) and T Cells Precede the Late Phase Reaction in Experimental Asthma , 2003, The Journal of experimental medicine.

[39]  C. Janeway,et al.  Signals and signs for lymphocyte responses , 1994, Cell.